PT  - JOURNAL ARTICLE
AU  - Mudalal, Mahmoud
AU  - Sun, Xiaolin
AU  - Li, Xue
AU  - Zhou, Yanmin
TI  - The evaluation of leukocyte-platelet rich fibrin as an anti-inflammatory autologous biological additive
AID  - 10.15537/smj.2019.7.24302
DP  - 2019 Jul 01
TA  - Saudi Medical Journal
PG  - 657--668
VI  - 40
IP  - 7
4099  - http://smj.org.sa/content/40/7/657.short
4100  - http://smj.org.sa/content/40/7/657.full
SO  - Saudi Med J2019 Jul 01; 40
AB  - Objectives: To investigate the use of leukocyte-platelet rich fibrin on suppressing the porphyromonas gingivalis (PG-LPS)-induced secretion of proinflammatory cytokines.Methods: This quantitative experimental study was conducted at the School and Hospital of Stomatology, Jilin University, Changchun, China, between September 2017 and January 2019. A modified technique was used to obtain human gingival fibroblast cells (HGFCs). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Cell Counting Kit-8 tests were established to determine the proliferation rate. Human gingival fibroblast cells were treated by PG-LPS at different periods and the isolated mRNA was subjected to reverse transcription polymerase chain reaction and real time quantitative polymerase chain reaction. The release of platelet-derived growth factor and transforming-growth factor-β1 at various time intervals was observed.Results: We successfully established a modified technique for the production of HGFCs culture. One µg/mL PG-LPS was the recommended concentration to inhibit fibroblast proliferation. The expression of the pro-inflammatory cytokines messenger ribnucleic acid was notably raised at 3 and 6 hours post-PG-LPS treatment. The cumulative release of growth factors peaked during the first 24 hours and the production continued for 10 days. However, the fibroblast expression of cytokines was significantly suppressed after treatment with leucocyte- and platelet-rich fibrin (L-PRF).Conclusion: This study provided a novel way of obtaining HGFCs and greater understanding of the clinical impacts through the assessment of the anti-inflammatory properties of L-PRF in vitro.